National Cancer Institute Seeks Pharmaceutical Partner to Develop Novel Cancer Treatment

Summary

The National Cancer Institute is seeking a pharmaceutical or biotechnology company to collaborate on developing new cancer treatments based on a novel class of compounds that inhibit vacuolar-type (H+)-ATPases, with the goal of rapid publication of research results and timely commercialization of products.